Original Article
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Discovery, Characterization, and Clinical Development of the Glucagon-Like Peptides
Discovery, characterization, and clinical development of the glucagon-like peptides Daniel J. Drucker, … , Joel F. Habener, Jens Juul Holst J Clin Invest. 2017;127(12):4217-4227. https://doi.org/10.1172/JCI97233. Harrington Prize Essay Endocrinology Gastroenterology The discovery, characterization, and clinical development of glucagon-like-peptide-1 (GLP-1) spans more than 30 years and includes contributions from multiple investigators, science recognized by the 2017 Harrington Award Prize for Innovation in Medicine. Herein, we provide perspectives on the historical events and key experimental findings establishing the biology of GLP-1 as an insulin-stimulating glucoregulatory hormone. Important attributes of GLP-1 action and enteroendocrine science are reviewed, with emphasis on mechanistic advances and clinical proof-of-concept studies. The discovery that GLP-2 promotes mucosal growth in the intestine is described, and key findings from both preclinical studies and the GLP-2 clinical development program for short bowel syndrome (SBS) are reviewed. Finally, we summarize recent progress in GLP biology, highlighting emerging concepts and scientific insights with translational relevance. Find the latest version: https://jci.me/97233/pdf The Journal of Clinical Investigation HARRINGTON PRIZE ESSAY Discovery, characterization, and clinical development of the glucagon-like peptides Daniel J. Drucker,1 Joel F. Habener,2 and Jens Juul Holst3 1Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. 2Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA. 3Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. sequences of cloned recombinant cDNA copies of messenger RNAs. -
Β Cell Tone Is Defined by Proglucagon Peptides Through Camp Signaling
β Cell tone is defined by proglucagon peptides through cAMP signaling Megan E. Capozzi, … , David A. D’Alessio, Jonathan E. Campbell JCI Insight. 2019;4(5):e126742. https://doi.org/10.1172/jci.insight.126742. Research Article Endocrinology Metabolism Paracrine interactions between pancreatic islet cells have been proposed as a mechanism to regulate hormone secretion and glucose homeostasis. Here, we demonstrate the importance of proglucagon-derived peptides (PGDPs) for α to β cell communication and control of insulin secretion. Signaling through this system occurs through both the glucagon-like peptide receptor (Glp1r) and glucagon receptor (Gcgr). Loss of PGDPs, or blockade of their receptors, decreases insulin secretion in response to both metabolic and nonmetabolic stimulation of mouse and human islets. This effect is due to reduced β cell cAMP and affects the quantity but not dynamics of insulin release, indicating that PGDPs dictate the magnitude of insulin output in an isolated islet. In healthy mice, additional factors that stimulate cAMP can compensate for loss of PGDP signaling; however, input from α cells is essential to maintain glucose tolerance during the metabolic stress induced by high-fat feeding. These findings demonstrate an essential role for α cell regulation of β cells, raising the possibility that abnormal paracrine signaling contributes to impaired insulin secretion in diabetes. Moreover, these findings support reconsideration of the role for α cells in postprandial glucose control. Find the latest version: https://jci.me/126742/pdf RESEARCH ARTICLE β Cell tone is defined by proglucagon peptides through cAMP signaling Megan E. Capozzi,1 Berit Svendsen,1 Sara E. -
2016 IES Annual Meeting Final Programme
ROYAL ACADEMY OF MEDICINE IN IRELAND IRISH JOURNAL OF MEDICAL SCIENCE Irish Endocrine Society 40th Annual Meeting 14th and 15th October 2016 Stormont Hotel, Belfast Local Organiser: Doctor Hamish Courtney, REVISEDRoyal Victoria Hospital, PROOF Belfast Irish Journal of Medical Science Volume XXX Supplement X DOI 10.1007/s11845-016-1482-y 123 123 Journal : Large 11845 Dispatch : 17-8-2016 Pages : 57 Article No. : 1482 h LE h TYPESET MS Code : 1482 h44CP h DISK Ir J Med Sci Disclosure statement This supplement is paid for by the Irish Endocrine Society. However the meeting costs are supported by the following commercial sponsors: Abbott Amgen Astra Zeneca Besins Healthcare BMS Boehringer Ingleheim Consilient Ipsen Janssen-Cilag Kyowa Kirin Lilly Menarini Merck Serono MSD Novartis Novo Nordisk Pfizer Sanofi REVISED PROOF 123 Journal : Large 11845 Dispatch : 17-8-2016 Pages : 57 Article No. : 1482 h LE h TYPESET MS Code : 1482 h44CP h DISK Ir J Med Sci Novo Lecture Nordisk Lecture 1976 D.K. O’Donovan 1977 S. Bloom 1978 J.H.S. Robertson 1979 A.G. Cudworth 1980 D.A.D. Montgomery 1981 Peter Watkins 1982 G. Joplin 1983 D.R. London 1984 A.X. Bertagna 1985 Malcolm Nattrass Laurence Kennedy 1986 Brian Frier JB Ferriss 1987 Maurice Scanlon TJ McKenna 1988 D.A. Heath AB Atkinson 1989 J. Ward GH Tomkin 1990 R. Volpe KD Buchanan 1991 Michael Besser PPA Smyth 1992 R.V. Ragontte DH Hadden 1993 Bruce Weintraub David Powell 1994 Oscar Croffard Patrick Bell 1995 Robert Lindsay Brian Sheridan 1996 C.R.W. Edwards Rosemary Freaney 1997 Stephanie Amiel David McCance 1998 Robert Turner Randle Hayes 1999 Ian Hay Sean K Cunningham 2000 Stephen O’Rahilly Michael Cullen 2001 Andre Lacroix Daphne Owens 2002 J. -
Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells
Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells. M Schalling, … , T Hökfelt, J F Rehfeld J Clin Invest. 1990;86(2):660-669. https://doi.org/10.1172/JCI114758. Research Article In previous studies we have shown that the gene encoding cholecystokinin (CCK) is expressed in spermatogenic cells of several mammalian species. In the present study we show that a gene homologous to the CCK-related hormone, gastrin, is expressed in the human testis. The mRNA hybridizing to a human gastrin cDNA probe in the human testis was of the same size (0.7 kb) as gastrin mRNA in the human antrum. By in situ hybridization the gastrinlike mRNA was localized to seminiferous tubules. Immunocytochemical staining of human testis revealed gastrinlike peptides in the seminiferous tubules primarily at a position corresponding to spermatids and spermatozoa. In ejaculated spermatozoa gastrinlike immunoreactivity was localized to the acrosome. Acrosomal localization could also be shown in spermatids with electron microscopy. Extracts of the human testis contained significant amounts of progastrin, but no bioactive amidated gastrins. In contrast, ejaculated sperm contained mature carboxyamidated gastrin 34 and gastrin 17. The concentration of gastrin in ejaculated human spermatozoa varied considerably between individuals. We suggest that amidated gastrin (in humans) and CCK (in other mammals) are released during the acrosome reaction and that they may be important for fertilization. Find the latest version: https://jci.me/114758/pdf Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells Martin Schalling,* Hhkan Persson,t Markku Pelto-Huikko,*9 Lars Odum,1I Peter Ekman,I Christer Gottlieb,** Tomas Hokfelt,* and Jens F. -
Development and Characterization of GLP-1 Total and Active V-PLEX
T1530-12-77 Development and Characterization of GLP-1 Total and Active V-PLEX® Assays Priscilla Krai, Jennifer Morgan, Lalitha Janaki, Jon Buhrman, Laure Moller, Colleen Kenten, Vivek Chitnis, Seth B. Harkins, David Stewart, and Jacob N. Wohlstadter Meso Scale Discovery, Rockville, Maryland, USA CONTACT INFORMATION: [email protected] PURPOSE CALIBRATION CURVES AND SPECIFICITY ACCURACY AND PRECISION Glucagon like peptide-1 (GLP-1), an incretin hormone, is a major target of interest for researchers studying metabolic, To assess the specificity of each assay, both V-PLEX GLP-1 Total and GLP-1 Active Kits were tested for Quality control samples were prepared by spiking calibrator into non-human serum matrix at three levels (high, neurologic, and cardiovascular disorders. After post-translational processing of proglucagon, the GLP-1 peptide is LIMITS OF DETECTION nonspecific binding to the following GLP-1 metabolites and other general metabolic targets. mid, and low) within the quantitative linear range of the assay. The controls were measured using a minimum of secreted in its bioactive form, which binds a specific receptor (GLP-1R) to stimulate insulin release. Once in circulation, Cross-reactivity at or below 0.02% is reported as not detected (ND). three replicates tested over multiple days and multiple operators for a total of at least 36 runs. The accuracy of The figure below demonstrates typical calibration curves for the analytes in the V-PLEX GLP-1 Total and however, the peptide is rapidly cleaved by proteases (e.g. DPP-IV), yielding several other metabolites that account for *Although weakly cross-reactive, Liraglutide and GLP-1 have nearly identical sequences and have the control determinations fell within 20% of the expected concentration with precision of less than 20% CV in the GLP-1 Active Kits. -
Lessons from Single and Double Incretin Receptor Knockout Mice
Regulatory Peptides 128 (2005) 125–134 www.elsevier.com/locate/regpep Review GIP and GLP-1 as incretin hormones: Lessons from single and double incretin receptor knockout mice Tanya Hansotia, Daniel J. Drucker* Department of Medicine, Banting and Best Diabetes Centre, Toronto General Hospital, and the University of Toronto, 200 Elizabeth Street MBRW4R-402, Toronto, Ontario, Canada M5G 2C4 Received 6 July 2004; received in revised form 8 July 2004; accepted 15 July 2004 Available online 25 August 2004 Abstract Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are gut-derived incretins secreted in response to nutrient ingestion. Both incretins potentiate glucose-dependent insulin secretion and enhance h-cell mass through regulation of h-cell proliferation, neogenesis and apoptosis. In contrast, GLP-1, but not GIP, inhibits gastric emptying, glucagon secretion, and food intake. Furthermore, human subjects with Type 2 diabetes exhibit relative resistance to the actions of GIP, but not GLP-1R agonists. The physiological importance of both incretins has been investigated through generation and analysis of incretin receptor knockout mice. Elimination of incretin receptor action in GIPRÀ/À or GLP-1RÀ/À mice produces only modest impairment in glucose homeostasis. Similarly, double incretin receptor knockout (DIRKO) mice exhibit normal body weight and normal levels of plasma glucagon and hypoglycemic responses to exogenous insulin. However, glucose-stimulated insulin secretion is significantly decreased following oral but not intraperitoneal glucose challenge in DIRKO mice and the glucose lowering actions of dipeptidyl peptidase-IV (DPP-IV) inhibitors are extinguished in DIRKO mice. Hence, incretin receptor signaling exerts physiologically relevant actions critical for glucose homeostasis, and represents a pharmacologically attractive target for development of agents for the treatment of Type 2 diabetes. -
Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J
The Open Nutrition Journal, 2009, 3, 5-7 5 Open Access Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J. Tomasik*, Krystyna Sztefko and Zdzislaw Szafran Department of Clinical Biochemistry, University Children`s Hospital, Krakow, Poland Abstract: Background: It is known that the low ambient temperature causes a considerable increase of appetite. The mechanisms underlying the changes of the amounts of the ingested food in relation to the environmental temperature has not been elucidated. The aim of this study was to investigate the effect of the short exposure to low ambient temperature on the plasma concentration of leptin and cholecystokinin. Methods: Sixteen healthy men, mean age 24.6 ± 3.5 years, BMI 22.3 ± 2.3 kg/m2, participated in the study. The concen- trations of plasma CCK and leptin were determined twice – before and after the 30 min. exposure to + 4 °C by using RIA kits. Results: The mean value of CCK concentration before the exposure to low ambient temperature was 1.1 pmol/l, and after the exposure 0.6 pmol/l (p<0.0005 in the paired t-test). The mean values of leptin before exposure (4.7 ± 1.54 μg/l) were also significantly lower than after the exposure (6.4 ± 1.7 μg/l; p<0.0005 in the paired t-test). However no significant cor- relation was found between CCK and leptin concentrations, both before and after exposure to low temperature. Conclusions: It has been known that a fall in the concentration of CCK elicits hunger and causes an increase in feeding activity. -
Supplementary Table 1. Clinico-Pathologic Features of Patients with Pancreatic Neuroendocrine Tumors Associated with Cushing’S Syndrome
Supplementary Table 1. Clinico-pathologic features of patients with pancreatic neuroendocrine tumors associated with Cushing’s syndrome. Review of the English/Spanish literature. Other hormones Age of Cortisol Other hormones Other ACTH Size (ICH or assay) ENETS Follow- Time Year Author Sex CS onset level (Blood syndromes or Site MET Type AH level (cm) corticotrophic Stage up (months) (years) (µg/dl) detection) NF other differentiation 1 1 1946 Crooke F 28 uk uk none no 4.5 H liver/peritoneum NET uk uk yes IV DOD 6 2 1956 Rosenberg 2 F 40 uk 92 none no 10 B liver NET uk uk yes IV PD 3 & p 3 1959 Balls F 36 uk elevated insulin Insulinoma 20 B liver/LNl/lung NET uk uk yes IV DOD 1 4 & 4 1962 Meador F 47 13~ elevated none no uk T liver/spleen NET ACTH uk yes IV uk 5 1963 Liddle5 uk uk uk elevated uk uk uk uk uk NET ACTH uk uk uk uk 6 1964 Hallwright6 F 32 uk uk none no large H LN/liver NET ACTH, MSH uk yes IV DOD 24 7 1965 Marks7 M 43 uk elevated insulin insulinomas 1.8 T liver NET uk uk yes IV DOD 7 8 1965 Sayle8 F 62 uk uk none carcinoidb 4 H LN/liver NET uk uk yes IV DOD 6 9 1965 Sayle8 F 15 uk uk none no 4 T no NET ACTH uk yes IIa DOD 5 9 b mesentery/ 10 1965 Geokas M 59 uk uk gastrin ZES large T NET uk uk yes IV DOD 2 LN/pleural/bone 11 1965 Law10 F 35 1.2 ∞ 91 gastrin ZESs uk B LN/liver NET ACTH, MSH gastrin yes IV PD 12 1967 Burkinshaw11 M 2 uk 72 none no large T no NET uk uk no uk AFD 12 13 1968 Uei12 F 9 uk uk none ZESs 7 T liver NET ACTH uk yes IV DOD 8 13 PTH, ADH, b gastrin, 14 1968 O'Neal F 52 13~ uk ZES uk T LN/liver/bone NET -
Glucose-Dependent Insulinotropic Polypeptide (GIP): from Prohormone to Actions in Endocrine Pancreas and Adipose Tissue
PHD THESIS DANISH MEDICAL BULLETIN Glucose-dependent Insulinotropic Polypeptide (GIP): From prohormone to actions in endocrine pancreas and adipose tissue Randi Ugleholdt The two incretins, glucagon-like peptide 1 (GLP-1) and glu- This review has been accepted as a thesis with two original papers by University of cose dependent insulinotropic polypeptide (gastric inhibitory Copenhagen 14th of December 2009 and defended on 28th of January 2010 peptide, GIP) have long been recognized as important gut hor- mones, essential for normal glucose homeostasis. Plasma levels Tutor: Jens Juul Holst of GLP-1 and GIP rise within minutes of food intake and stimulate Official opponents: Jens Frederik Rehfeld, Baptist Gallwitz & Thure Krarup pancreatic β-cells to release insulin in a glucose-dependent man- ner. This entero-insular interaction is called the incretin effect and Correspondence: Department of Biomedical Sciences, Cellular and Metabolic Re- search Section, University of Copenhagen, Faculty of Health Sciences, Blegdamsvej accounts for up to 70% of the meal induced insulin release in man 3B build. 12.2, 2200 Copenhagen N, Denmark and via this incretin effect, the gut hormones facilitate the uptake of glucose in muscle, liver and adipose tissue (2). Although the E-mail: [email protected] pancreatic effects of these two gut hormones have been the target of extensive investigation both hormones also have nu- merous extrapancreatic effects. Thus, GLP-1 decreases gastric Dan Med Bull 2011;58:(12)B4368 emptying and acid secretion and affects appetite by increasing fullness and satiety thereby decreasing food intake and, if main- THE TWO ORIGINAL PAPERS ARE tained at supraphysiologic levels, eventually body weight (3). -
Preprocholecystokinin Processingin the Normal Human Anterior Pituitary
Proc. Nati. Acad. Sci. USA Vol. 84, pp. 3019-3023, May 1987 Medical Sciences Preprocholecystokinin processing in the normal human anterior pituitary (cell differentiation/peptide hormone/radioimmunoassay) JENS F. REHFELD University Department of Clinical Chemistry, Rigshospitalet, DK-2100 Copenhagen, Denmark Communicated by Diter von Wettstein, January 2, 1987 (receivedfor review October 28, 1986) ABSTRACT The processing of preprocholecystokinin in (12). Two pituitary corticotrophic tumors from patients with human pituitary extracts was investigated using gel and ion- Nelson syndromes were obtained by transsphenoidal resec- exchange chromatography monitored by sequence-specific tion. The tumor specimens and the normal pituitary lobes radioimmunoassays before and after incubation with trypsin, were frozen in liquid nitrogen and stored at -80'C until carboxypeptidase B, and arylsulfatase. Whereas the neural extraction. The frozen tumors or lobes were minced (each lobe contained only the bioactive a-carboxyamidated cholecys- lobe separately), boiled for 20 min in redistilled water (pH tokinin (CCK) peptides (32 pmol/g), of which CCK-8 predom- 6.6, 10 ml/g of tissue), homogenized, and centrifuged. The inated, the anterior lobe contained substantial amounts ofthree pellet was extracted in an equal volume of 0.5 M CH3COOH large nonamidated procholecystokinin fragments (95 pmol/g; at 10°C and centrifuged; the supernatants were stored at Mrs, 9000, 7000, and 5000) and small amounts of a-amidated -20°C until analysis. The neutral and acid extracts diluted CCK (8.3 pmol/g). The latter occurred only in the following from 1:3 to 1:10,000 were assayed with sequence-specific large molecular forms: component I, CCK-58, and traces of CCK radioimmunoassays before and after treatment with CCK-33. -
A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function
The Journal of Neuroscience, July 15, 2000, 20(14):5564–5573 A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function Seema Bhatnagar,2 Victor Viau,1 Alan Chu,1 Liza Soriano,1 Onno C. Meijer,1 and Mary F. Dallman1 1Department of Physiology, University of California at San Francisco, San Francisco, California 94143-0444, and 2Department of Psychology, University of Michigan, Ann Arbor, Michigan 48109 Chronic stress alters hypothalamic-pituitary-adrenal (HPA) re- ceptor antagonist PD 135,158 into the PVTh before restraint in sponses to acute, novel stress. After acute restraint, the posterior control and chronically cold-stressed rats. ACTH responses to division of the paraventricular thalamic nucleus (pPVTh) exhibits restraint stress were augmented by PD 135,158 only in chroni- increased numbers of Fos-expressing neurons in chronically cally stressed rats but not in controls. In addition, CCK-B recep- cold-stressed rats compared with stress-naı¨vecontrols. Further- tor mRNA expression in the pPVTh was not altered by chronic more, lesions of the PVTh augment HPA activity in response to cold stress. We conclude that previous chronic stress specifically novel restraint only in previously stressed rats, suggesting that facilitates the release of CCK into the pPVTh in response to the PVTh is inhibitory to HPA activity but that inhibition occurs acute, novel stress. The CCK is probably secreted from neurons only in chronically stressed rats. In this study, we further exam- in the lateral parabrachial, the periaqueductal gray, and/or the ined pPVTh functions in chronically stressed rats. -
What Is Pancreatic Polypeptide and What Does It Do?
What is Pancreatic Polypeptide and what does it do? This document aims to evaluate current understanding of pancreatic polypeptide (PP), a gut hormone with several functions contributing towards the maintenance of energy balance. Successful regulation of energy homeostasis requires sophisticated bidirectional communication between the gastrointestinal tract and central nervous system (CNS; Williams et al. 2000). The coordinated release of numerous gastrointestinal hormones promotes optimal digestion and nutrient absorption (Chaudhri et al., 2008) whilst modulating appetite, meal termination, energy expenditure and metabolism (Suzuki, Jayasena & Bloom, 2011). The Discovery of a Peptide Kimmel et al. (1968) discovered PP whilst purifying insulin from chicken pancreas (Adrian et al., 1976). Subsequent to extraction of avian pancreatic polypeptide (aPP), mammalian homologues bovine (bPP), porcine (pPP), ovine (oPP) and human (hPP), were isolated by Lin and Chance (Kimmel, Hayden & Pollock, 1975). Following extensive observation, various features of this novel peptide witnessed its eventual classification as a hormone (Schwartz, 1983). Molecular Structure PP is a member of the NPY family including neuropeptide Y (NPY) and peptide YY (PYY; Holzer, Reichmann & Farzi, 2012). These biologically active peptides are characterized by a single chain of 36-amino acids and exhibit the same ‘PP-fold’ structure; a hair-pin U-shaped molecule (Suzuki et al., 2011). PP has a molecular weight of 4,240 Da and an isoelectric point between pH6 and 7 (Kimmel et al., 1975), thus carries no electrical charge at neutral pH. Synthesis Like many peptide hormones, PP is derived from a larger precursor of 10,432 Da (Leiter, Keutmann & Goodman, 1984). Isolation of a cDNA construct, synthesized from hPP mRNA, proposed that this precursor, pre-propancreatic polypeptide, comprised 95 residues (Boel et al., 1984) and is processed to produce three products (Leiter et al., 1985); PP, an icosapeptide containing 20-amino acids and a signal peptide (Boel et al., 1984).